394 related articles for article (PubMed ID: 29655584)
1. Nanoemulsion adjuvant-driven redirection of T
O'Konek JJ; Landers JJ; Janczak KW; Goel RR; Mondrusov AM; Wong PT; Baker JR
J Allergy Clin Immunol; 2018 Jun; 141(6):2121-2131. PubMed ID: 29655584
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens.
Farazuddin M; Landers JJ; Janczak KW; Lindsey HK; Finkelman FD; Baker JR; O'Konek JJ
Front Immunol; 2021; 12():599296. PubMed ID: 33717078
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
[TBL] [Abstract][Full Text] [Related]
4. Intranasal delivery of allergen in a nanoemulsion adjuvant inhibits allergen-specific reactions in mouse models of allergic airway disease.
Baker JR; Rasky AJ; Landers JJ; Janczak KW; Totten TD; Lukacs NW; O'Konek JJ
Clin Exp Allergy; 2021 Oct; 51(10):1361-1373. PubMed ID: 33999457
[TBL] [Abstract][Full Text] [Related]
5. Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy.
Smarr CB; Hsu CL; Byrne AJ; Miller SD; Bryce PJ
J Immunol; 2011 Nov; 187(10):5090-8. PubMed ID: 21976774
[TBL] [Abstract][Full Text] [Related]
6. Intranasal nanoemulsion vaccine confers long-lasting immunomodulation and sustained unresponsiveness in a murine model of milk allergy.
O'Konek JJ; Landers JJ; Janczak KW; Lindsey HK; Mondrusov AM; Totten TD; Baker JR
Allergy; 2020 Apr; 75(4):872-881. PubMed ID: 31557317
[TBL] [Abstract][Full Text] [Related]
7. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
Int Immunol; 1999 Jul; 11(7):1131-8. PubMed ID: 10383946
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice.
Morafo V; Srivastava K; Huang CK; Kleiner G; Lee SY; Sampson HA; Li AM
J Allergy Clin Immunol; 2003 May; 111(5):1122-8. PubMed ID: 12743580
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization.
van Wijk F; Hoeks S; Nierkens S; Koppelman SJ; van Kooten P; Boon L; Knippels LM; Pieters R
J Immunol; 2005 Jan; 174(1):174-9. PubMed ID: 15611239
[TBL] [Abstract][Full Text] [Related]
10. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure.
Wavrin S; Bernard H; Wal JM; Adel-Patient K
Int Arch Allergy Immunol; 2014; 164(3):189-99. PubMed ID: 25034179
[TBL] [Abstract][Full Text] [Related]
12. Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy.
Wiedermann U; Jahn-Schmid B; Repa A; Kraft D; Ebner C
Int Arch Allergy Immunol; 1999; 118(2-4):129-32. PubMed ID: 10224359
[TBL] [Abstract][Full Text] [Related]
13. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
[TBL] [Abstract][Full Text] [Related]
14. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.
Strid J; Hourihane J; Kimber I; Callard R; Strobel S
Clin Exp Allergy; 2005 Jun; 35(6):757-66. PubMed ID: 15969667
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
Takabayashi K; Libet L; Chisholm D; Zubeldia J; Horner AA
J Immunol; 2003 Apr; 170(7):3898-905. PubMed ID: 12646659
[TBL] [Abstract][Full Text] [Related]
16. Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression.
Thottingal TB; Stefura BP; Simons FE; Bannon GA; Burks W; HayGlass KT;
J Allergy Clin Immunol; 2006 Oct; 118(4):905-14. PubMed ID: 17030245
[TBL] [Abstract][Full Text] [Related]
17. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
18. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
Srivastava KD; Qu C; Zhang T; Goldfarb J; Sampson HA; Li XM
J Allergy Clin Immunol; 2009 Feb; 123(2):443-51. PubMed ID: 19203662
[TBL] [Abstract][Full Text] [Related]
19. Current Trend in Immunotherapy for Peanut Allergy.
Joo Chan C; Richardo T; Lim RLH
Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
[TBL] [Abstract][Full Text] [Related]
20. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana.
Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N
Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
